OpenURL Connection Search

Select item for more details and to access through your institution.

Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor.
Published in:
Langenbeck's Archives of Surgery, 2013, v. 398, n. 2, p. 239, doi. 10.1007/s00423-012-1039-0
By:
- Ott, Katja;
- Blank, Susanne;
- Becker, Karen;
- Langer, Rupert;
- Weichert, Wilko;
- Roth, Wilfried;
- Sisic, Leila;
- Stange, Annika;
- Jäger, Dirk;
- Büchler, Markus;
- Siewert, Jörg-Rüdiger;
- Lordick, Florian
Publication type:
Article
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, p. 905, doi. 10.1245/s10434-015-4617-x
By:
- Springfeld, Christoph;
- Wiecha, Christiane;
- Kunzmann, Romy;
- Heger, Ulrike;
- Weichert, Wilko;
- Langer, Rupert;
- Stange, Annika;
- Blank, Susanne;
- Sisic, Leila;
- Schmidt, Thomas;
- Lordick, Florian;
- Jäger, Dirk;
- Grenacher, Lars;
- Bruckner, Tom;
- Büchler, Markus;
- Ott, Katja
Publication type:
Article
Assessment of Diffusion-Weighted MRI and <sup>18</sup>F-Fluoro- Deoxyglucose PET/CT in Monitoring Early Response to Neoadjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction.
Published in:
Journal of Gastrointestinal & Liver Diseases, 2013, v. 22, n. 1, p. 45
By:
- Weber, Marc-André;
- Bender, Karen;
- von Gall, Carl Christian;
- Stange, Annika;
- Grünberg, Katharina;
- Ott, Katja;
- Haberkorn, Uwe;
- Kauczor, Hans-Ulrich;
- Zechmann, Christian
Publication type:
Article
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.
Published in:
2018
By:
- Berger, Anne Katrin;
- Lücke, Stephan;
- Abel, Ulrich;
- Haag, Georg Martin;
- Grüllich, Carsten;
- Stange, Annika;
- Dietrich, Mareike;
- Apostolidis, Leonidas;
- Freitag, Angelika;
- Trierweiler, Claudia;
- von Gall, Carl;
- Ose, Jennifer;
- Giesel, Frederik;
- Weber, Tim Frederik;
- Lordick, Florian;
- Haberkorn, Uwe;
- Jäger, Dirk
Publication type:
journal article
Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation.
Published in:
Gastric Cancer, 2015, v. 18, n. 2, p. 314, doi. 10.1007/s10120-014-0367-x
By:
- Blank, Susanne;
- Lordick, Florian;
- Bader, Franz;
- Burian, Maria;
- Dobritz, Martin;
- Grenacher, Lars;
- Becker, Karen;
- Weichert, Wilko;
- Langer, Rupert;
- Sisic, Leila;
- Stange, Annika;
- Jäger, Dirk;
- Büchler, Markus;
- Bruckner, Thomas;
- Siewert, Jörg;
- Ott, Katja
Publication type:
Article
Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).
Published in:
2012
By:
- Rahbari, Nuh N;
- Lordick, Florian;
- Fink, Christine;
- Bork, Ulrich;
- Stange, Annika;
- Jäger, Dirk;
- Luntz, Steffen P;
- Englert, Stefan;
- Rossion, Inga;
- Koch, Moritz;
- Büchler, Markus W;
- Kieser, Meinhard;
- Weitz, Jürgen;
- SYNCHRONOUS trial group
Publication type:
journal article
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
Published in:
BMC Cancer, 2011, v. 11, n. 1, p. 266, doi. 10.1186/1471-2407-11-266
By:
- Lorenzen, Sylvie;
- Gall, Carl von;
- Stange, Annika;
- Haag, Georg M.;
- Weitz, Jürgen;
- Haberkorn, Uwe;
- Lordick, Florian;
- Weichert, Wilko;
- Abel, Ulrich;
- Debus, Jürgen;
- Jäger, Dirk;
- Münter, Marc W.
Publication type:
Article

Found: 7

Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor.

Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.

Assessment of Diffusion-Weighted MRI and <sup>18</sup>F-Fluoro- Deoxyglucose PET/CT in Monitoring Early Response to Neoadjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction.

Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.

Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation.

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.